Evidence check: Helicobacter in the context of longevity

Helicobacter pylori (H. pylori) is a bacterium colonizing the stomach, with both detrimental and potentially beneficial associations for longevity. On one hand, chronic infection increases risks of peptic ulcers, gastric cancer, and atrophic gastritis, which can shorten lifespan. On the other hand, some studies suggest H. pylori may reduce risks of asthma, allergies, and esophageal adenocarcinoma, possibly via immune modulation. However, evidence is mixed and highly dependent on strain virulence, host genetics, and environment. In high-prevalence populations (e.g., developing countries) negative effects often dominate, while in Western countries the decline of H. pylori correlates with rising autoimmune and allergic diseases. For longevity, individual risk assessment is needed: eradication may be beneficial for symptomatic patients or those with family history of gastric cancer, but for asymptomatic individuals without risk factors, benefit is unclear. The provided context lacks specific information on H. pylori, so this answer is based on general medical evidence. Caveat: No direct sources from the given context.